1:30 PM - 3:30 PM Friday, January 14
During this session, important topics in neuromodulation will be covered, including: Psychiatric Neuroengineering, FDA Approval Standards for PCLC Systems, and Fundamentals of Physiologic Closed-Loop Control Systems.
- Plenary Session III: Late-Breaking Clinical Trials
- Connecting with the Future: Neuromodulation Art and Science Made Easy with Technology
- Device Troubleshooting for APPs
- Advances in Neuromodulation in Cancer Pain
- Beyond Pain and Nerves: Applied Neuromodulation for Vascular, Non-Vascular, Visceral and Residual COVID-19 Co-Morbid Conditions